Alyeska Investment Group L.P. Sells 74,955 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alyeska Investment Group L.P. reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 195,016 shares of the medical equipment provider's stock after selling 74,955 shares during the period. Alyeska Investment Group L.P. owned 0.05% of Intuitive Surgical worth $101,791,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Down 0.3 %

Shares of NASDAQ ISRG traded down $1.36 during midday trading on Tuesday, reaching $530.46. The company's stock had a trading volume of 1,125,053 shares, compared to its average volume of 1,625,419. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00. The company has a 50 day moving average price of $503.33 and a 200 day moving average price of $534.46. The company has a market cap of $190.13 billion, a price-to-earnings ratio of 82.76, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the business earned $1.50 EPS. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now owns 473 shares of the company's stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,313 shares of company stock worth $17,229,143. Company insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Evercore ISI cut their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Erste Group Bank cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Raymond James boosted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Finally, BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.